Trial Profile
Targeted Small Airways Therapy in Persistent Asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms ANDA3
- 02 Aug 2018 Status changed from recruiting to completed.
- 20 Apr 2018 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 20 Apr 2018 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.